A Randomized, Multi-center, Phase 3 Study of Nivolumab in Combination with Ipilimumab Compared to Sorafenib or Lenvatinib as First-Line Treatment in Participants with Advanced Hepatocellular Carcinoma.

Roberts, S., Lewis, P., George, J., Zekry, A., O'Beirne, J., Tse, E., McLachlan, S., Eastgate, M., Ananda, S. S. & Davison, S.


Project: Research

Ingestible capsules for sensing gut metabolites

Kalantar-zadeh, K., Gibson, P., Muir, J., McSweeney, C., Hebblewhite, M. & Berean, K. J.


Project: Research

Not started